DOI QR코드

DOI QR Code

Pancreatic duct lavage cytology combined with a cell-block method for patients with possible pancreatic ductal adenocarcinomas, including pancreatic carcinoma in situ

  • Hiroaki Kusunose (Department of Gastroenterology, Sendai City Medical Center) ;
  • Shinsuke Koshita (Department of Gastroenterology, Sendai City Medical Center) ;
  • Yoshihide Kanno (Department of Gastroenterology, Sendai City Medical Center) ;
  • Takahisa Ogawa (Department of Gastroenterology, Sendai City Medical Center) ;
  • Toshitaka Sakai (Department of Gastroenterology, Sendai City Medical Center) ;
  • Keisuke Yonamine (Department of Gastroenterology, Sendai City Medical Center) ;
  • Kazuaki Miyamoto (Department of Gastroenterology, Sendai City Medical Center) ;
  • Fumisato Kozakai (Department of Gastroenterology, Sendai City Medical Center) ;
  • Hideyuki Anan (Department of Gastroenterology, Sendai City Medical Center) ;
  • Kazuki Endo (Department of Gastroenterology, Sendai City Medical Center) ;
  • Haruka Okano (Department of Gastroenterology, Sendai City Medical Center) ;
  • Masaya Oikawa (Department of Surgery, Sendai City Medical Center) ;
  • Takashi Tsuchiya (Department of Surgery, Sendai City Medical Center) ;
  • Takashi Sawai (Department of Pathology, Sendai City Medical Center) ;
  • Yutaka Noda (Department of Gastroenterology, Sendai City Medical Center) ;
  • Kei Ito (Department of Gastroenterology, Sendai City Medical Center)
  • Received : 2021.12.08
  • Accepted : 2022.04.04
  • Published : 2023.05.30

Abstract

Background/Aims: This study aimed to clarify the efficacy and safety of pancreatic duct lavage cytology combined with a cell-block method (PLC-CB) for possible pancreatic ductal adenocarcinomas (PDACs). Methods: This study included 41 patients with suspected PDACs who underwent PLC-CB mainly because they were unfit for undergoing endoscopic ultrasonography-guided fine needle aspiration. A 6-Fr double lumen catheter was mainly used to perform PLC-CB. Final diagnoses were obtained from the findings of resected specimens or clinical outcomes during surveillance after PLC-CB. Results: Histocytological evaluations using PLC-CB were performed in 87.8% (36/41) of the patients. For 31 of the 36 patients, final diagnoses (invasive PDAC, 12; pancreatic carcinoma in situ, 5; benignancy, 14) were made, and the remaining five patients were excluded due to lack of surveillance periods after PLC-CB. For 31 patients, the sensitivity, specificity, and accuracy of PLC-CB for detecting malignancy were 94.1%, 100%, and 96.8%, respectively. In addition, they were 87.5%, 100%, and 94.1%, respectively, in 17 patients without pancreatic masses detectable using endoscopic ultrasonography. Four patients developed postprocedural pancreatitis, which improved with conservative therapy. Conclusions: PLC-CB has an excellent ability to detect malignancies in patients with possible PDACs, including pancreatic carcinoma in situ.

Keywords

Acknowledgement

We would like to thank Fumiyoshi Fujishima, MD, PhD, Department of Pathology, Tohoku University School of Medicine, Miwa Uzuki, MD, PhD, Department of Nursing, Faculty of Medical Science and Welfare, Tohoku Bunka Gakuen University, and Toru Furukawa, MD, PhD, Department of Investigative Pathology, Tohoku University Graduate School of Medicine for histocylogical evaluations using cytological specimens and resected specimens from all subjects, and all staff in the Department of Pathology at Sendai City Medical Center for performing immunohistochemical staining in this study. In addition, we are grateful to Dr. Brian Breedlove, Associate Professor, Tohoku University School of Science, for English proofreading.

References

  1. ASGE Standards of Practice Committee, Eloubeidi MA, Decker GA, et al. The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia. Gastrointest Endosc 2016;83:17-28.
  2. Renelus BD, Jamorabo DS, Boston I, et al. Endoscopic ultrasound-guided fine needle biopsy needles provide higher diagnostic yield compared to endoscopic ultrasound-guided fine needle aspiration needles when sampling solid pancreatic lesions: a meta-analysis. Clin Endosc 2021;54:261-268.
  3. Chung MJ, Park SW, Kim SH, et al. Clinical and technical guideline for endoscopic ultrasound (EUS)-guided tissue acquisition of pancreatic solid tumor: Korean Society of Gastrointestinal Endoscopy (KSGE). Clin Endosc 2021;54:161-181.
  4. Nakaizumi A, Tatsuta M, Uehara H, et al. Usefulness of simple endoscopic aspiration cytology of pancreatic juice for diagnosis of early pancreatic neoplasm: a prospective study. Dig Dis Sci 1997;42:1796-1803.
  5. Koshita S, Noda Y, Ito K, et al. Pancreatic juice cytology with immunohistochemistry to detect malignancy and histologic subtypes in patients with branch duct type intraductal papillary mucinous neoplasms of the pancreas. Gastrointest Endosc 2017;85:1036-1046.
  6. Noda Y, Fujita N, Kobayashi G, et al. Prospective randomized controlled study comparing cell block method and conventional smear method for pancreatic juice cytology. Dig Endosc 2012;24:168-174.
  7. Koshita S, Noda Y, Kanno Y, et al. Value of repeated cytology for intraductal papillary mucinous neoplasms of the pancreas with high risk potential of malignancy: is it a promising method for monitoring a malignant transformation? Pancreatology 2020;20:1164-1174.
  8. Sai JK, Nobukawa B, Matsumura Y, et al. Pancreatic duct lavage cytology with the cell block method for discriminating benign and malignant branch-duct type intraductal papillary mucinous neoplasms. Gastrointest Endosc 2013;77:726-735.
  9. Kanno Y, Koshita S, Ogawa T, et al. Predictive value of localized stenosis of the main pancreatic duct for early detection of pancreatic cancer. Clin Endosc 2019;52:588-597.
  10. Noda Y, Fujita N, Kobayashi G, et al. Diagnostic efficacy of the cell block method in comparison with smear cytology of tissue samples obtained by endoscopic ultrasound-guided fine-needle aspiration. J Gastroenterol 2010;45:868-875.
  11. Guidelines of the Papanicolaou Society of Cytopathology for fine-needle aspiration procedure and reporting. Diagn Cytopathol 1997;17:239-247.
  12. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991;37:383-393.
  13. Iiboshi T, Hanada K, Fukuda T, et al. Value of cytodiagnosis using endoscopic nasopancreatic drainage for early diagnosis of pancreatic cancer: establishing a new method for the early detection of pancreatic carcinoma in situ. Pancreas 2012;41:523-529.
  14. Satoh T, Kikuyama M, Kawaguchi S, et al. Acute pancreatitis-onset carcinoma in situ of the pancreas with focal fat replacement diagnosed using serial pancreatic-juice aspiration cytologic examination (SPACE). Clin J Gastroenterol 2017;10:541-545.
  15. Peters ML, Eckel A, Mueller PP, et al. Progression to pancreatic ductal adenocarcinoma from pancreatic intraepithelial neoplasia: results of a simulation model. Pancreatology 2018;18:928-934.
  16. Mikata R, Ishihara T, Tada M, et al. Clinical usefulness of repeated pancreatic juice cytology via endoscopic naso-pancreatic drainage tube in patients with pancreatic cancer. J Gastroenterol 2013;48:866-873.
  17. Mouri T, Sasaki T, Serikawa M, et al. A comparison of 4-Fr with 5-Fr endoscopic nasopancreatic drainage catheters: a randomized, controlled trial. J Gastroenterol Hepatol 2016;31:1783-1789.
  18. Ito K, Fujita N, Noda Y, et al. Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial. J Gastroenterol 2010;45:1183-1191.
  19. Dumonceau JM, Andriulli A, Elmunzer BJ, et al. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) guideline - updated June 2014. Endoscopy 2014;46:799-815.